The table also shows, for example, that for participants with f-Hb of 80–119 μg/g, 35.4 per 1000 (just under 4%) have CRC (more estimations on prevalence and sensitivity for all abnormalities by f-Hb are given in Tables S3–S5). This evidence concerns the gene GSTM1 and colorectal carcinoma.